Inhaled Pharmaceutical Product Development Perspectives - 1st Edition - ISBN: 9780128122099, 9780128123362

Inhaled Pharmaceutical Product Development Perspectives

1st Edition

Challenges and Opportunities

Authors: Anthony Hickey
eBook ISBN: 9780128123362
Paperback ISBN: 9780128122099
Imprint: Elsevier
Published Date: 23rd November 2017
Page Count: 110
Sales tax will be calculated at check-out Price includes VAT/GST
75.41
56.56
56.56
56.56
60.33
56.56
56.56
60.33
64.95
48.71
48.71
48.71
51.96
48.71
48.71
51.96
55.95
41.96
41.96
41.96
44.76
41.96
41.96
44.76
69.95
52.46
52.46
52.46
55.96
52.46
52.46
55.96
Unavailable
Price includes VAT/GST
98.14
73.61
73.61
73.61
78.51
73.61
73.61
78.51
64.95
48.71
48.71
48.71
51.96
48.71
48.71
51.96
55.95
41.96
41.96
41.96
44.76
41.96
41.96
44.76
69.95
52.46
52.46
52.46
55.96
52.46
52.46
55.96
Unavailable
Price includes VAT/GST

eBook format help

Institutional Subscription

Support Center

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Introduction–Historical Perspective
Inhaled Products
Scientific Advances
Technical Advances
Regulatory Advances
Conclusion
References
2. Dosage Forms
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Other Products
Specialized Formulations
Manufacturing
Performance Criteria
Conclusion
References
3. Quality and Performance Tests
Physical Tests for Drup And EXcipient Characterization
Aerodynamic Particle Size Distribution
Delivered Dose and Uniformity
Other Factors
IVIVC Considerations
Statistical Parameters
Stability
Conclusion
References
4. Preclinical and Clinical Considerations
Lung Deposition Imaging
Lung Deposition Modeling
Animal Models
Cell Culture
Pharmacokinetics
Pharmacodynamics
Conclusion
References
5. Regulatory Strategy
International Regulations
United States Regulations
General Principles
Conclusion
References
6. General Conclusion
Appendices
Index

Description

Inhaled Pharmaceutical Product Development Perspectives: Challenges and Opportunities describes methods and procedures for consideration when developing inhaled pharmaceuticals, while commenting on product development strategies and their suitability to support regulatory submission. It bridges the gap between the aspirations of scientists invested in new technology development and the requirements that must be met for any new product.

The book brings together emerging analytical and inhalation technologies, providing perspectives that illuminate formulation and device design, development, regulatory compliance, and practice. Focusing on underlying scientific and technical principles known to be acceptable from the current regulatory perspective, this monograph will remain useful as a high-level guide to inhaled product development for the foreseeable future.

Key Features

  • Discusses development strategies and best practices in the context of regulatory requirements
  • Written by a broadly qualified expert drawing on the knowledge and critical opinions of key individuals in the field
  • Includes a foreword by Charles G. Thiel

Readership

Pharmaceutical scientists, formulation scientists, analytical chemists in the pharmaceutical sciences, regulatory officers, medical practitioners, patients and health scientists, graduate level pharmaceutical sciences students

Details

No. of pages:
110
Language:
English
Copyright:
© Elsevier 2018
Published:
Imprint:
Elsevier
eBook ISBN:
9780128123362
Paperback ISBN:
9780128122099

Ratings and Reviews

About the Authors

Anthony Hickey Author

Anthony J. Hickey, PhD, DSc, currently serves as a distinguished fellow and senior research pharmacologist at RTI International. He has more than 30 years of academic and research experience in the areas of pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design, and device development. His research has focused on improving understanding of the physiology, pharmacology, and immunology of the lungs. Throughout his career, Dr. Hickey has worked on intranasal and inhaled vaccine development and drug delivery for diseases affecting the respiratory tract, including asthma, chronic obstructive lung disease, tuberculosis, and cystic fibrosis. He has also studied the performance of powders and particles in drug and vaccine delivery systems. He received his PhD and DSc degrees in pharmaceutical sciences from the University of Aston in Birmingham, a master’s degree in toxicology from the University of Birmingham, and a bachelor’s degree in biology from Portsmouth Polytechnic.

Affiliations and Expertise

RTI International, Research Triangle Park, NC, USA

Request Quote

Tax Exemption

We cannot process tax exempt orders online. If you wish to place a tax exempt order please contact us.